Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IL-13 PE38QQR (IL-13 toxin): Began Phase I testing

NeoPharm Inc. (NEO), Bannockburn,

Read the full 44 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE